Stock Product Stage Comments ----- --------------- --------------------- ----------------------------- AEZS Cetrorelix Phase 3 BPH Q3 '09 Efficacy results due. AUXL Xiaflex Phase 3 BLA filed for Dupuytren's Contracture (and PH2 for peyronie's and frozen shoulder syndrome) BPAX Libigel Phase 3 ~2010 Submit Adequate Safety? CHTP Droxidopa Pivotal Phase III Orthostatic hypotension. Results expected 02/09. CRGB Abiraterone Phase 3 Prostate cancer DYAX DX-88 for HAE BLA filed 9/24/08 (CABG indication partnered w CBST) GNVC TNFerade Pivotal Phase III Pancreatic cancer INFI Retaspimycin Phase 3 GI stromal tumors JAV Dyloject Phase III Approved in UK. Post operative Pain (injectable) JAV Ketamine Phase III Acute moderate-to-severe pain (intranasal) NTII Viprinex Phase 3 Interim analysis January '09. Stroke Drug, high chance of failure. OREX Contrave Phase 3 Obesity OXGN Zybrestat Phase 3 Anaplastic thyroid cancer Pharming Rhucin Pre-BLA Rejected in EU Protalix prGCD Phase III Gaucher's disease. Not enough cash for a commercial infrastructure RPRX Proellex Phase 3 Uterine fibroids SVNT Puricase BLA filed Treatment refratory gout
Procedure for Updating Table
1. Copy the text in this post into a word processor.
2. Using a monospace font (e.g. Courier) to facilitate tabular alignment, make your additions and modifications, inserting them in the table in alphabetical order. NOTE: use spaces rather than tab characters.
3. Add a brief note in the “Edits:” line atop the table to describe your changes.
4. Insert the iHub formatting directives: Put [ pre ] at the beginning of the table without the surrounding spaces, and put [ /pre ] at the end of the table without the surrounding spaces.
Late-Stage Products Looking for a Home I was googling for something and came across this list. I liked the idea but its interesting to see how many flops there were